IBMI President Chi-Huey Wong stated that Taiwan possesses three rare global advantages: AI chip manufacturing capabilities, high-quality medical services, and comprehensive clinical data accumulated via National Health Insurance. These form the foundation for AI-driven biotechnology and smart healthcare. He argued that Taiwan's biotech industry is at a critical crossroads and must evolve from "Made in Taiwan" to "Created in Taiwan."
Read more
